High grade bladder cancer
Original Article Prognostic value of the tumor-stroma ratio in patients with T1 high-grade bladder cancer undergoing transurethral resection of bladder tumor
9
PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer
6
The optimal management of T1 high grade bladder cancer
5
Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study
6
Methylation of HOXA9 and ISL1 predicts patient outcome in high grade non invasive bladder cancer
12
Original Article SKIP expression is correlated with clinical prognosis in patients with bladder cancer
7
Total antioxidant capacity and certain cytokines in patients with bladder Cancer
5
Low compliance with guidelines for re staging in high grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta
6
Original Article Expression of p-FOXO3/FOXO3 in bladder cancer and its correlation with clinicopathology and tumor recurrence
6
Original Article Expression of TMEM40 in bladder cancer and its correlation with clinicopathological parameters
8
Advanced primary urethral cancer: a case report
6
Original Article Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer
8
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer
14
Neutrophil lymphocyte ratio as a predictor of recurrence and progression in patients with high grade pT1 bladder cancer
6
Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis
6
Damrauer_unc_0153D_14699.pdf
148
Which urine marker test provides more diagnostic value in conjunction with standard cytology- ImmunoCyt/uCyt+ or Cytokeratin 20 expression
6
Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy
6
Bladder preservation approach versus radical cystectomy for high grade non muscle invasive bladder cancer: a meta analysis of cohort studies
15
The Correlation between CD44 and ABCG2 Expression and Pathological Grades of Bladder Carcinoma
6